Choosing Between At-Home and IV Ketamine
One of the most common questions we receive from patients considering treatment is deceptively simple: should I come in for IV ketamine therapy for depression, or is the at-home program the right choice for me?
The honest answer is that neither option is universally better. The right choice depends on a patient’s clinical history, symptom severity, lifestyle, support system, and a constellation of other factors that our team works through carefully with every individual. Because we offer both IV infusion therapy and medically supervised at-home ketamine, we can have this conversation from a place of genuine clinical breadth rather than a one-size-fits-all recommendation.
Understanding IV Ketamine
To compare these two treatment modalities fairly, it helps to understand what each one involves. IV ketamine infusions are administered intravenously in our clinic, which means the medication bypasses the digestive system and enters the bloodstream directly. This route offers rapid onset and precise dosing control.
Because the infusion is titrated in real time by Dr. Philip Hansen, a board-certified anesthesiologist, the dose can be adjusted during the session based on how a patient is responding, and any adverse reactions can be addressed promptly. Sessions typically last approximately 45 to 60 minutes for psychiatric indications, and patients rest for a period before being discharged with a support person.
Understanding At-Home Ketamine
At-home ketamine therapy involves a different delivery mechanism and patient experience. In our program, patients receive sublingual, or under-the-tongue, ketamine lozenges prescribed through our telehealth platform. These lozenges are taken at home in a comfortable, prepared environment with a responsible support person present throughout the session.
The at-home ketamine treatment in Albany, NY is an off-label treatment involving a controlled substance, and it requires full medical supervision, including a thorough intake evaluation, preparation guidance, real-time check-in availability, and integration support following each session. It is not a mail-order supplement or a self-directed protocol; it is a medically supervised program operated under the same clinical rigor as our in-office infusions, adapted to a different delivery modality.
How the Routes and Experiences Differ
The pharmacokinetics of sublingual ketamine differ from IV. Sublingual administration has lower bioavailability than IV, and the onset, peak effects, and duration can differ by route and by individual. For a deeper look at how treatment timelines compare, see our guide on how long ketamine treatment lasts.
Those distinctions do not make one option universally better. They help inform a treatment plan that fits a patient’s clinical picture, comfort level, home support, and preferred treatment setting.
How We Help Patients Choose
When a patient comes to us asking how to choose, our clinical team considers several dimensions. We look at the severity and chronicity of the presenting condition, treatment history, and whether the monitoring and dose adjustment available during an IV session would be useful for that patient’s care. We also consider factors such as a history of poor oral absorption, significant anxiety about the subjective intensity of treatment, or other medical considerations that may affect which modality is appropriate.
We also consider access and logistics. For patients in Albany proper, coming to our clinic for IV infusions may be straightforward. But for patients in more rural parts of upstate New York, including the Catskill corridor, Adirondack foothills, and western Capital Region, travel to Albany for multiple sessions may represent a real hardship. For those patients, and for patients with severe social anxiety, agoraphobia, physical disabilities, or medical conditions that complicate travel, the at-home program may reduce a meaningful barrier to care.
The key requirement is that a responsible adult is present throughout every at-home session. This is non-negotiable, not a suggestion.
Our treatment planning process for starting ketamine treatment is designed to account for all of these factors before we recommend a path forward.
The Role of the Treatment Environment
Some patients do their best processing in the privacy of their own home, surrounded by familiar objects and the presence of a trusted partner or family member. Others find the clinical setting reassuring. The presence of medical staff, the structure of the appointment, and the separation from their domestic environment can all contribute to a better experience.
These are real psychological factors, and we take them seriously in the treatment planning conversation.
Considering an Individualized Care Plan
For patients who are genuinely uncertain, we may discuss how IV and at-home treatment could fit into a broader care plan. Some patients may begin with IV infusions and later transition to at-home maintenance sessions. Others may be better positioned to begin with at-home care.
Results vary by individual, and there is no default sequence that is right for everyone. The goal is to build a plan that is appropriate for the individual patient, not to steer every patient toward one modality. Our post on the benefits of at-home ketamine therapy for depression and anxiety explores what that experience can look like for patients who choose that path.
Ongoing Support at Home
One thing we want to emphasize is that “at-home” does not mean “without support.” Our at-home program involves preparation consultations, session guidance, and integration follow-up at every stage. We are reachable during sessions and track patient progress closely.
The clinical relationship is maintained throughout, and we adjust the program as needed based on how patients respond. Discuss with your provider which modality is most appropriate given your full clinical picture, home support situation, and treatment goals.
Cost and Access
The cost of the two programs differs, and we discuss pricing openly at intake. Coverage may vary, and we review practical considerations as part of the consultation process.
We do not push patients toward either option based on cost. We focus on the option that is most appropriate for their clinical needs, circumstances, and goals.
Frequently Asked Questions
For additional practical details, visit our frequently asked questions page.
Is at-home ketamine as effective as IV ketamine?
Both modalities can be appropriate, but they involve different routes of administration, settings, and monitoring structures. Because individual response and circumstances vary, we do not treat either option as the universal standard. We evaluate each patient individually and recommend the modality that best fits their specific situation.
What is required to be eligible for at-home ketamine therapy?
Eligibility for our at-home program requires a thorough intake evaluation, medical clearance, a confirmed responsible support person who will be present throughout every session, and a stable home environment appropriate for the experience. Certain medical and psychiatric considerations may affect at-home candidacy or mean a different care plan is more appropriate. We determine eligibility through our consultation process.
Can I switch from IV ketamine to at-home after my initial series?
Yes. This is a pathway we discuss with patients who respond well to IV infusions and want a more accessible option for maintenance. When appropriate, the transition is managed carefully, with dose calibration that accounts for the difference in bioavailability between IV and sublingual administration.
How do I know if I’m a candidate for the at-home program?
Schedule a consultation with our team. We review your clinical history, severity of your condition, support system, geographic situation, and any contraindications to determine candidacy. We do not enroll patients into at-home programs without confidence that the setting and support structure are appropriate.
Does Albany Ketamine Infusions offer at-home ketamine therapy outside of Albany?
Yes. Our at-home telehealth program serves patients in New York, New Jersey, Florida, and Texas. Patients outside these states should contact us to discuss current availability.
Key Takeaways
- IV ketamine and at-home ketamine use different routes of administration and provide different treatment settings.
- At-home ketamine is an off-label, controlled-substance treatment requiring full medical supervision and a responsible support person at every session.
- The right choice depends on condition severity, clinical history, support system, geography, and individual preference, not a single universal standard.
- For some patients, care may include a transition between modalities; for others, one option may be the right fit from the start.
- Results vary by individual. Discuss with your provider which treatment modality best fits your clinical situation and treatment goals.
Conclusion
At Albany Ketamine Infusions, we think the question of which ketamine treatment is right for you deserves a real answer, not a brochure. Our team takes the time to understand who you are, what you have tried, and what your life looks like, so that the recommendation we make is genuinely tailored to you.
If you are ready to have that conversation, we invite you to schedule a consultation with Dr. Hansen and our care team.
About Dr. Philip Hansen
Dr. Philip Hansen is a board-certified anesthesiologist who trained at Albany Medical Center. He established Albany Ketamine Infusions in partnership with Dr. Brooks, building on his training at NY Ketamine Infusions. Dr. Hansen graduated from the University of Kansas School of Medicine and holds membership in the American Society of Anesthesia, the American Medical Association, and the New York State Society of Anesthesiologists. He provides medical oversight for both in-office IV ketamine infusions and at-home telehealth ketamine programs for patients across New York, New Jersey, Florida, and Texas.
Works Cited
Barbara, A. M., Xie, W., Mahood, Q., & Hamson, A. (2024). Ketamine for adults with treatment-resistant depression or posttraumatic stress disorder: A 2023 update: Rapid review. Canadian Agency for Drugs and Technologies in Health.
Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016). Ketamine: A review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clinical Pharmacokinetics, 55(9), 1059–1077.
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., Summergrad, P., & Nemeroff, C. B. (2017). A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry, 74(4), 399–405.
Medical Disclaimer
The information provided in this blog is for educational purposes only and does not constitute medical advice. Treatment outcomes vary by individual. Results may vary. Please consult with a qualified healthcare provider before beginning any new treatment. Discuss with your provider whether this treatment is appropriate for you.